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Malnutrition (Subjective Global Assessment) scores and serum albumin levels,
but not body mass Index values, at initiation of dialysis are independent
predictors of mortality: A 10-year clinical cohort study
Abstract
OBJECTIVE: To examine the associations between demographic, clinical, lifestyle, and nutritional
parameters at the start of dialysis and mortality, including the combined effects on nutritional parameters,
which were seldom investigated in the literature. DESIGN: Ten-year retrospective clinical cohort study.
SETTING: Dialysis unit of a metropolitan tertiary teaching hospital in Sydney, Australia. SUBJECTS:
Incident dialysis patients (n = 167; hemodialysis, 57.5%; male, 61.7%; age, 65.3 ± 13.6 years; diabetic,
24.5%) who commenced on a planned dialysis program. METHODS: Associations were examined
between all-cause mortality and baseline demographics, including age and gender; clinical and lifestyle
characteristics, including glomerular filtration rate, smoking habits, presence of comorbidities (e.g.,
coronary artery disease, diabetes mellitus, and peripheral vascular disease); and nutritional parameters,
including body mass index (BMI), serum albumin (s-albumin) levels, and subjective global assessment
score (SGA). Associations with combination values for malnutrition, s-albumin (65 years, P < .0001),
presence of peripheral vascular disease (P < .0001), reduced s-albumin levels (P = .01), and malnutrition
scores (P = .02) independently predicted mortality. Being overweight and obese (BMI: ≥26 kg/m(2)) did
not show any advantage on survival (P = .73). Being malnourished and overweight (or obese) was
associated with a 3-fold increase in mortality risk (adjusted hazard ratio [HR], 2.96; 95% confidence
interval [CI], 1.12 to 7.33; P = .02) compared with being well nourished with a BMI <26 kg/m(2) (referent).
Compared with being well nourished (SGA = A), being malnourished with normal or low s-albumin was
associated with higher risk (HR, 2.06; 95% CI, 1.06 to 4.00; P = .03 and HR, 2.86; 95% CI, 1.65 to 4.94; P <
.0001, respectively). There was no statistical difference between mortality risks through any combination
of s-albumin and BMI values (P = .54). CONCLUSION: Malnutrition and reduced s-albumin levels were
found to be independent predictors of mortality, whereas being overweight and obese did not show
protective effects.
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Malnutrition (Subjective Global
Assessment) Scores and Serum Albumin
Levels, but not Body Mass Index Values,
at Initiation of Dialysis are Independent
Predictors of Mortality: A 10-Year Clinical
Cohort Study
Maria Chan, BSc(Hons), MNutrDiet, GradDip ExSpSc, AdvAPD,*†‡
John Kelly, MBBS, MD,‡§ Marijka Batterham, MSc(Nutr&Diet), MMedStat, PhD,
GStat, AdvAPD,{ and Linda Tapsell, PhD, FDAA†
Objective: To examine the associations between demographic, clinical, lifestyle, and nutritional parameters at the
start of dialysis and mortality, including the combined effects on nutritional parameters, which were seldom investigated in the literature.
Design: Ten-year retrospective clinical cohort study.
Setting: Dialysis unit of a metropolitan tertiary teaching hospital in Sydney, Australia.
Subjects: Incident dialysis patients (n 5 167; hemodialysis, 57.5%; male, 61.7%; age, 65.3 6 13.6 years; diabetic,
24.5%) who commenced on a planned dialysis program.
Methods: Associations were examined between all-cause mortality and baseline demographics, including age
and gender; clinical and lifestyle characteristics, including glomerular ﬁltration rate, smoking habits, presence of comorbidities (e.g., coronary artery disease, diabetes mellitus, and peripheral vascular disease); and nutritional parameters, including body mass index (BMI), serum albumin (s-albumin) levels, and subjective global assessment score
(SGA). Associations with combination values for malnutrition, s-albumin (,3.3 vs. $3.3 g/dL), and BMI (,26 vs. $26
kg/m2) were also examined.
Results: Median survival was 54.2 months (interquartile range, 23 to 83), and 52.1% of patients were malnourished
(SGA score B and C) at the start of dialysis. Advanced age (classiﬁed as .65 years, P , .0001), presence of peripheral
vascular disease (P , .0001), reduced s-albumin levels (P 5 .01), and malnutrition scores (P 5 .02) independently
predicted mortality. Being overweight and obese (BMI: $26 kg/m2) did not show any advantage on survival (P 5
.73). Being malnourished and overweight (or obese) was associated with a 3-fold increase in mortality risk (adjusted
hazard ratio [HR], 2.96; 95% conﬁdence interval [CI], 1.12 to 7.33; P 5 .02) compared with being well nourished with
a BMI ,26 kg/m2 (referent). Compared with being well nourished (SGA 5 A), being malnourished with normal or low
s-albumin was associated with higher risk (HR, 2.06; 95% CI, 1.06 to 4.00; P 5 .03 and HR, 2.86; 95% CI, 1.65 to 4.94;
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P , .0001, respectively). There was no statistical difference between mortality risks through any combination of
s-albumin and BMI values (P 5 .54).
Conclusion: Malnutrition and reduced s-albumin levels were found to be independent predictors of mortality,
whereas being overweight and obese did not show protective effects.
Crown Copyright Ó 2012 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. All rights
reserved.

This article has an online CPE activity available at www.kidney.org/professionals/CRN/ceuMain.cfm

P

ROTEIN ENERGY WASTING and poor
nutritional status are common in patients
with end-stage kidney disease (ESKD) on maintenance dialysis.1-3 These are strong predictors of
mortality and morbidity and are associated with
poor quality of life.4,5 Factors affecting nutrition
in uremic patients include (1) disturbance of energy, protein, and nutrients metabolism,6 (2) metabolic acidosis,7 (3) anorexia, taste change, and
poor appetite that may lead to suboptimal dietary
intake,8-10 (4) dialysis procedures per se,4 such as bioincompatibility, inadequate dialysis, protein and
other nutrient losses, and peritoneal dialysis (PD)
dialysate-induced glucose loading and sense of
fullness,11 (5) hormonal derangement,12 (6) comorbidities, such as cardiovascular disease and diabetes mellitus, (7) infection and intercurrent
illnesses, (8) chronic inﬂammation,2 (9) altered
muscle metabolism13 and physical inactivity,14
(10) loss of residual renal function,15 (11) psychosocial issues16 and poor food management skill,
and (12) conditions associated with various stages
of lifecycle that require additional nutritional attention, such as menopause, aging-related sarcopenia, and poor dentition. Many of these
nutrition abnormalities emerge during the progressive decline of renal function before dialysis
is required.8,17
In the dialysis population, nutritional factors
found to predict mortality risk are anthropometric
measures, such as low weight-to-height ratio,18 low
body mass index (BMI), and unintentional weight
loss19; abnormal laboratory results, such as high
level of C-reactive protein (CRP)20 and low levels
of lymphocytes, parathyroid hormone, serum albumin, prealbumin, and hemoglobin19,21-25; poor appetite,26 muscle wasting,27 suboptimal intakes of
energy and protein,9 low exercise capacity,14 and
poor functional capacity measured by hand grip
strength27; and malnutrition score using subjective
global assessment (SGA).28 Many of these abnormalities present at the start of dialysis and predicted
poor outcomes.4,27,28 However, there has been

much debate on the prognostic signiﬁcance of
s-albumin-CRP,28,29 BMI,30-33 and timing of initiation of dialysis.34,35 It is necessary to understand
the relationships between mortality and these modiﬁable factors so that predialysis intervention can be
considered to improve outcomes. The aims of the
present study were (1) to describe the demographic,
clinical, and nutritional characteristics in a cohort of
ESKD patients who commenced on planned dialysis program in our unit, (2) to examine the associations between these factors and mortality, and (3) to
examine the combined effects of nutritional factors
on mortality risk, as these methods were seldom investigated in the previous studies.

Patients and Methods
This was a retrospective clinical cohort study involving all incident hemodialysis (HD) and PD patients at the renal unit of The George Hospital,
Sydney, Australia, between August 1, 2000 and
July 31, 2005. All patients were followed until
death, or they were censored at transplant or at
the end of the observational period on July 31,
2010. This means all patients completed at least
5 years of follow-up during the 10-year study period. Inclusion criteria were ESKD patients who
were older than 18 years and who commenced
a planned dialysis program after gradual decline
of renal function without history of acute kidney
injury (AKI) and renal replacement therapy
(RRT). Initiation of dialysis was recommended
by the patients’ primary nephrologists based on
clinical judgments (e.g., when glomerular ﬁltration rate [GFR] was ,7 mL/minutes/1.73 m2
or indication of uncontrolled uremic symptoms
such as volume overload). Exclusion criteria
were patients in whom dialysis was initiated because of AKI with or without recovering renal
function, previous history of RRT, planned early
discontinuation of dialysis program from our
unit (e.g., living donor transplantation or transfer
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to another unit), and incomplete assessment by the
dietitian within 4 weeks of dialysis initiation.
Clinical and demographic data extracted from
the hospital clinical notes and the Australia and
New Zealand Dialysis and Transplant Registry
(ANZDATA) included age; gender; race; smoking
history (never smoked or combined ex- and current smokers); late referral to nephrologists, deﬁned as ,3 months under specialist care before
starting dialysis; and comorbidities, such as coronary artery disease (CAD), cerebral vascular disease (CVD), diabetes mellitus (DM), chronic
lung disease (CLD), and peripheral vascular disease
(PVD). ANZDATA classiﬁed the presence of
comorbidity as ‘‘yes,’’ ‘‘suspected,’’ or ‘‘no’’; data
of ‘‘yes’’ and ‘‘suspected’’ were combined as ‘‘presence of ’’ for analysis in this study. Mortality and
cause of death were also extracted.
In line with the clinical guidelines,36 which are
based on the latest best evidence and expert opinion, if a high level of evidence did not exist or was
inconclusive, all patients were assessed by the renal
unit dietitians, including the author M.C., as part
of the routine care. Anthropometric measures included for analysis were height (m), edema-free
body weight (kg), BMI 5 weight O height2
(m/kg2), and weight history (in particular if any
unintentional weight loss occurred in the previous
6 months for SGA rating). The previous routine
blood results before the ﬁrst dialysis session were
extracted from clinical notes. These included
s-albumin (reference range, 3.3 to 5.3 g/dL) and
serum creatinine results to calculate GFR using
the Cockcroft-Gault equation. The survival risk
between the early and late starting groups was
compared using the Initiating Dialysis Early and
Late (IDEAL) trial intended cutoff of $7 and ,7
mL/minutes/1.73 m2 as early and late initiation,
respectively37; further analyses were performed at
cutoffs of 8, 9, and 10 mL/minutes/1.73 m2. To
eliminate the negative effect of acute-phase response of s-albumin due to the insertion of PD
catheter, the most recent s-albumin readings before the procedures were used. Other assessment
performed by the renal dietitian(s) was SGA,38
which categorizes patients as A 5 well nourished,
B 5 mild-moderately malnourished, and C 5 severely malnourished, based on the patient’s medical history and physical examination. Urea kinetic
studies were routinely performed for all patients
throughout the study period to meet the optimal
national dialysis targets.39 The clinical practice
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guidelines36 deﬁne healthy range for BMI as 22
to 26 kg/m2; we considered BMI $26 kg/m2 as
obese or overweight. Additional analyses were
performed according to the World Health Organization–deﬁned categories40 of underweight,
healthy weight range, overweight, and obese
(BMI: ,18.5, 18.5 to 25.0, 25 to 30, and $30
kg/m2, respectively) as well as renal-speciﬁc BMI
categories36,41 of undernourished, ideal range,
overweight, and obese (BMI: ,23, 23 to 26, 26
to 30, and $30 kg/m2, respectively). The combined effects of malnutrition (classiﬁed by SGA
score B or C), s-albumin (,3.3 vs. $3.3 g/dL),
and BMI (,26 vs. $26 kg/m2) were also examined. For example, the combined effects of SGA
and BMI were determined using the following
forms of categorization: group 1 (SGA 5 A 1
BMI: ,26 kg/m2), group 2 (SGA 5 A 1 BMI:
$26 kg/m2), group 3 (SGA 5 B and C 1 BMI:
,26 kg/m2), and group 4 (SGA 5 B and C 1
BMI: $26 kg/m2). Similar forms of categorization
applied to SGA and s-albumin as well as s-albumin
and BMI combinations.
All tests were performed using the statistical
software SPSS version 18 (SPSS Inc, Chicago,
IL). Continuous variables were expressed as
mean 6 standard deviation for normally distributed data and as medians with interquartile ranges
for non-normally distributed data. For continuous
variables, comparisons between groups were performed using unpaired sample t test for normally
distributed variables or the Mann-Whitney test
for non-normally distributed variables, whereas
categorical variables were compared using the c2
test. Survival analysis was performed using the
Kaplan-Meier method (univariate analysis), and
Cox proportional hazard analysis (multivariate
analysis) was used to assess the independent association between baseline parameters and mortality.
Effect of age (.65 years), GFR (,7 mL/minutes/1.73 m2), s-albumin (,3.3 g/dL), and BMI
($26 and $30 kg/m2) as continuous and categorical variables were also examined. P ,.05 was considered to be statistically signiﬁcant.
The study was approved by the ethics committee of the South Eastern Sydney and Illawarra Area
Health Service, NSW, Australia.

Results
Dialysis was initiated in 330 patients in the deﬁned period. Of these, 167 patients (50.6%) met
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the inclusion criteria. One hundred sixty-three
patients (49.4%) were excluded from analysis
because of AKI with or without recovering renal
function (32.8%), previous history of RRT
(2.1%), planned early discontinuation of dialysis
program from our unit (10.3%), and other causes
(e.g., ,18 years of age, incomplete dietitian assessment within 4 weeks of enrollment, or missing
data; 4.2%). The mean age (6standard deviation)
of the studied subjects was 65.3 6 13.6 years
(male, 61.7%). Of these patients, 57.5% were on
HD and the rest were on PD at day 90 after enrollment; 64 patients (38.3%) switched dialysis modality during the study period. Similar survival rates
were reported in the literature for both modalities28,42 even after switching from one to the
other.43 As we found similar results by the
Kaplan-Meier analysis (P 5 .89), all HD and PD
data were combined for analysis. Twenty-eight patients (16.8%) received a kidney transplant after
entry to the study.
The baseline demographic, clinical, and nutritional characteristics of the studied patients at
the initiation of dialysis are listed in Table 1.

Late referral (,90 days) to the nephrologists was
noted in 8.5% of patients, and dialysis was commenced with a mean GFR of 8.0 6 2.7 mL/minutes/1.73 m2. Apart from body weight and serum
creatinine, there was no statistical difference between male and female patients for all other demographic, clinical, and nutritional parameters.
In all, 111 patients (66.6%) died, including 2 of
the transplanted patients, by the end of the observation period. Three patients were transferred to
other hospitals, but their survival data were
obtained from the ANZDATA for analysis. Median follow-up time was 53.0 (interquartile range,
23 to 83) months, with 96.5 (76.3 to 108.8) versus
29 (17.0 to 53.0) months for survivors and nonsurvivors, respectively. The causes of ESKD and
death are listed in Table 2. The main cause of
ESKD was diabetic nephropathy (24%). The
most common cause of death was withdrawal of
dialysis due to refusal and quality of life measures
(21.6%).
Among the patients studied, dialysis was initiated early in 37.2% ($7 mL/minutes/1.73 m2)
and late in 62.8% (,7 mL/minutes/1.73 m2),

Table 1. Demographic, Clinical, and Nutritional Characteristics of the Studied Subjects at Baseline
Parameters

Total

Male

Female

Number (%)
167
103 (61.7%)
64 (38.3%)
Demographics
Age (year)
65.3 6 13.6
65.8 6 13.9
64. 6 13.1
Race, white (%)
83.3
83.5
82.8
Clinical and comorbidities
Hemodialysis at 3 month (%)
57.5
62.1
50.0
Serum creatinine (mmol/L)
800.6 6 288.1 867.4 6 314.4 683.0 6 199.3*
8.0 6 2.7
7.8 6 2.7
8.2 6 2.7
Glomerular ﬁltration rate (mL/minutes/1.73 m2)
Late referral† (%)
8.5
10.6
4.7
Smoking (positive history)‡ (%)
43.7
47.3
35.0
Chronic lung disease§ (%)
15.8
15.5
16.4
Coronary artery disease{ (%)
46.2
48.5
42.6
Peripheral vascular disease** (%)
24.5
24.5
24.6
Cerebral vascular disease†† (%)
23.9
22.4
26.3
Diabetes mellitus (%)
33.5
34
32.8
Nutritional
Serum albumin (g/dL)
3.1 6 0.5
3.1 6 0.5
3.2 6 0.5
Weight (kg)
69.5 6 17.1
73.6 6 14.5
62.8 6 18.9*
25.9 6 6.9
25.9 6 4.4
25.9 6 7.7
Body mass index (kg/m2)
Malnourished, subjective global assessment score B and C (%)
52.1
48.5
57.8
P value is for comparison of the gender groups.
*P , .0001.
†Data missing in 2 patients.
‡Data missing in 10 patients.
§Data missing in 9 patients.
{Data missing in 9 patients.
**Data missing in 9 patients.
††Data missing in 9 patients.
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Table 2. Causes of End-Stage Kidney Disease
and Mortality
Causes

%

Causes of end-stage kidney disease (n 5 167)
Chronic glomerulonephritis
21.6
Diabetic nephropathy
24.0
Renovascular disease/hypertensive
18.6
nephrosclerosis
Adult polycystic kidney disease
5.4
Analgesic nephropathy
9.6
IgA nephropathy
6.0
Reﬂux nephropathy/congenital abnormality 4.8
Other or unknown causes
9.0
Causes of death (n 5 111)
Myocardial infarction
9.0
Cardiovascular accident
1.8
Cardiac arrest
11.7
Sepsis/infection
15.3
Other causes and illnesses
18.0
Withdrawal due to:
Refusal/quality of life measures
21.6
Cerebrovascular comorbidities
12.6
Peripheral vascular comorbidities
4.5
Malignancy
2.7
Unknown causes
2.7

with a mean GFR of 9.4 6 2.2 versus 5.5 6 1.0
mL/minutes/1.73 m2, respectively; P , .0001.
The early-start group in comparison with the
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late-start group had signiﬁcantly higher BMI
(27.5. 6 6.3 vs. 23.3 6 3.9 kg/m2, P , .0001)
and included fewer malnourished patients (43.8%
vs. 66.1%, c2 5 7.8, P 5.005). There was no statistical difference between the 2 groups for all other
variables. Kaplan-Meier analysis showed no statistical difference in mortality between the 2 groups
(P 5.79). Further analysis did not show any statistical difference in mortality between the early- versus late-start groups, with the GFR cutoff of 8 mL/
minutes/1.73 m2 (10.2 6 1.2 vs. 6.1 6 2.2), P ,
.0001; 9 mL/minutes/1.73 m2 (11.1 6 1.5
vs. 6.6 6 2.1), P , .0001; or 10 mL/minutes/
1.73 m2 (12.0 6 1.6 vs. 6.9 6 2.1), P , .0001.
Our data indicated that GFR levels at which dialysis started were not found to have any association
with mortality risk.
Among the lifestyle and comorbidity parameters, PVD was independently associated with
higher mortality risk (P ,.0001), whereas the signiﬁcance of CAD disappeared in the adjusted analyses (P 5.10). Smoking and all other comorbidities
did not show any statistically signiﬁcant effect on
mortality risks (Table 3).
Fifty-eight percent of patients had s-albumin
levels ,3.3 g/dL (reference range, 3.3 to 5.3 g/
dL). The low–s-albumin group, when compared

Table 3. Cox Proportional Hazards Analysis (Multivariate Model) of Factors Affecting Morality
Parameters
Age (per year increase)
Age (.65 years)
Gender (male)
Glomerular ﬁltration rate
(per mL/minutes increase)
Hemodialysis
s-albumin (per g/dL increase)
s-albumin (,3.3 g/dL)
Body mass index (per kg increase)
Body mass index ($30 kg/m2)
Body mass index ($26 kg/m2)
Malnourished, subjective global
assessment score B and C
Smoking (positive history)
Chronic lung disease
Coronary artery disease
Peripheral vascular disease
Cerebral vascular disease
Diabetes mellitus

Unadjusted Hazard Ratios
(95% Conﬁdence Interval)

P Value

Adjusted Hazard Ratios
(95% Conﬁdence Interval)*

P Value

1.08 (1.05-1.11)
2.76 (1.51-5.06)
1.31 (0.84-2.04)
1.09 (0.98-1.21)

,.0001
,.001
NS (0.23)
NS (0.10)

1.08 (1.05-1.12)
3.06 (1.70-5.51)
1.33 (0.86-2.06)
1.07 (0.97-1.17)

,.0001
,.0001
NS (0.20)
NS (0.10)

0.67 (0.43-1.06)
0.92 (0.87-0.98)
1.60 (0.95-2.71)†
0.97 (0.92-1.03)
0.68 (0.36-1.29)
0.91 (0.52-1.59)
1.76 (1.01-3.05)

NS (0.09)
.01
.08
NS (0.30)
NS (0.23)
NS (0.73)
.046

0.75 (0.48-1.16)
0.93 (0.89-0.98)
1.86 (1.17-2.97)†
0.97 (0.92-1.03)
0.67 (0.36-1.27)
0.91 (0.52-1.59)
1.74 (1.11-2.72)

NS (0.19)
.01
.01
NS (0.30)
NS (0.22)
NS (0.73)
.02

1.46 (0.95-2.23)
0.85 (0.50-1.45)
1.71 (1.04-2.81)
2.62 (1.57-4.37)
1.01 (0.61-1.67)
1.10 (0.68-1.75)

NS (0.09)
NS (0.56)
.04
,.0001
NS (0.98)
NS (0.71)

1.45 (0.96-2.19)
0.86 (0.50-1.45)
1.45 (0.94-2.19)
2.42 (1.57-3.73)
1.01 (0.61-1.67)
1.09 (0.69-1.74)

NS (0.08)
NS (0.56)
NS (0.10)
,.0001
NS (1.01)
NS (0.71)

NS, nonsigniﬁcant.
*Analysis with age as categorical variable unless stated otherwise. Hazard ratio adjusted for all other variables including
age, gender, dialysis modality, s-albumin, body mass index, subjective global assessment, smoking, and all co-morbidities.
†Analysis with age as continuous variable.
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with patients with normal s-albumin levels, had
signiﬁcantly lower s-albumin (2.8 6 0.3 vs. 3.5 6
0.3 g/dL, P , .0001), lower GFR (7.3 6 2.3 vs.
8.8 6 2.9 mL/minutes/1.73 m2, P , .0001), and
higher prevalence of malnutrition (66.3% vs.
34.2%, c2 5 16.9, P ,.0001). There was no statistical difference between the 2 groups for all other
variables. Cox proportional hazard model revealed
that the measure of s-albumin, as both a continuous
and categorical variable, was independently associated with survival; P 5 .01 and .01, respectively
(Table 3).
More than half of the patients (55.1%) were
overweight or obese (BMI: $26 kg/m2), and
17.4% of patients were obese (BMI: $30
kg/m2). Kaplan-Meier analysis indicated no statistical difference in mortality risk between patients with BMI ,26 and $26 kg/m2
(overweight and obese), P 5 .08 and ,30 or
$30 kg/m2 (obese) groups, P 5 .11. After adjusting for all other variables, Cox proportional
hazards analysis indicated similar effects (P 5
.73 and 0.22, respectively; Table 3). KaplanMeier analysis showed no statistical difference
in mortality between the 4 World Health Organization BMI categories40 (P 5 .26) nor among
the renal-speciﬁc BMI categories (P 5 .72).36,41
Within the cohort, 47.9%, 41.9%, and 10.2% of
patients were rated as well nourished (SGA 5 A),
mildly to moderately malnourished (SGA 5 B),
and severely malnourished (SGA 5 C), respectively. Kaplan-Meier analysis indicated a signiﬁcant
difference in the mortality risk between the 3
groups (P , .0001). After adjusting for all other
variables using the Cox proportional hazard
model, the survival curves of SGA B and C
merged, and the combined malnourished group
(SGA 5 B and C, 52.1%) showed signiﬁcantly
higher mortality risk compared with the wellnourished group (SGA 5 A) (adjusted hazard ratio
[HR], 1.74; 95% conﬁdence interval [CI], 1.11 to
2.72; P 5.02; Table 3 and Fig. 1). Therefore, malnutrition was found independently associated with
mortality. It is worth noting that the wellnourished group had signiﬁcantly more diabetic
patients than the malnourished group (41.4% vs.
26.4%, c2 5 4.1, P 5 .04). The SGA A group
had signiﬁcantly higher BMI (28.9 6 6.3 kg/m2)
compared with the SGA B and C group (23.1 6
3.7 kg/m2), P , .0001. It is important to note
that 24.5% of overweight or obese patients
(BMI: $26 kg/m2) were rated as malnourished

Figure 1. Adjusted survival curves for SGA evaluated at the start of dialysis. SGA, subjective
global assessment: A 5 well nourished, B&C 5
malnourished.

(SGA B and C) and within the malnourished
group (SGA B and C) 21% of patients were overweight or obese (BMI: $26 kg/m2).
When the combined effects of SGA and BMI
were examined, after adjusting for all other variables, the SGA 5 B and C 1 BMI: $26 kg/m2
group was associated with an almost 3-fold increase
in mortality risk (HR, 2.96; 95% CI, 1.12 to 7.33;
P 5 .02) compared with SGA 5 A 1 BMI ,26

Figure 2. Adjusted survival curves of the combined
effects of SGA and BMI evaluated at the start of
dialysis. Note: Group 1 versus 2 (P 5 .73), group 1
versus 3 (P 5 .19), group 1 versus 4 (P 5 .02), group
2 versus 3 (P 5 .14), group 2 versus 4 (P 5 .007),
group 3 versus 4 (P 5 .07). SGA, subjective global
assessment: A 5 well nourished, B&C 5 malnourished; BMI, body mass index in kg/m2.
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kg/m2 group (referent) (Fig. 2), although the mean
BMI of the SGA 5 B and C 1 BMI $26 kg/m2
group was signiﬁcantly higher than the SGA 5 A
1 BMI ,26 kg/m2 group (28.4 6 1.9 vs. 23.2 6
2.2 kg/m2), P , .0001. The SGA 5 B and C 1
BMI $26 kg/m2 group had an almost 2-fold higher
mortality risk (HR, 1.77; 95% CI, 0.95 to 3.30; P 5
.07) compared with the SGA 5 B and C 1 BMI
,26 kg/m2 group despite a signiﬁcant higher
mean BMI of 28.4 6 1.9 kg/m2 versus 21.8 6
2.8 kg/m2, P ,.0001. This means, among the malnourished groups, those overweight or obese
tended to perform worse.
When the combined effects of SGA and
s-albumin were examined (Fig. 3), no statistical
difference in mortality risk was observed between
the SGA 5 A 1 s-albumin $3.3 g/dL or SGA 5
A 1 s-albumin ,3.3 g/dL group (HR, 1.25; 95%
CI, 0.65 to 2.45; P 5.51), although the latter had
signiﬁcantly lower level of s-albumin (3.5 6 0.2
vs. 2.9 6 0.4 g/dL, P , .0001). In comparison
with SGA 5 A 1 s-albumin $3.3 g/dL group
(referent), the SGA 5 B and C 1 s-albumin
$3.3 g/dL group was associated with a 2-fold
(HR, 2.06; 95% CI, 1.06 to 4.00; P 5.03) increase
in mortality risk despite no difference in s-albumin
levels (3.5 6 0.2 vs. 3.5 6 0.3 g/dL, P , .90).
Among the SGA B and C groups with s-albumin
$3.3 g/dL or ,3.3 g/dL, no statistical difference
in mortality risk (P 5 .26) was observed despite

Figure 3. Adjusted survival curves of the combined
effects of SGA and s-albumin evaluated at the start
of dialysis. Note: Group 1 versus 2 (P 5 .51), group 1
versus 3 (P 5 .03), group 1 versus 4 (P , .0001),
group 2 versus 3 (P 5 .16), group 2 versus 4 (P 5
.004), group 3 versus 4 (P 5 .26). SGA, subjective
global assessment: A 5 well nourished, B&C 5 malnourished; Alb, s-albumin in g/dL.
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the statistical difference in s-albumin levels (3.5 6
0.3 vs. 2.8 6 0.3 g/dL, P # .0001). An almost
3-fold increase in mortality risk was observed
for SGA 5 B and C 1 s-albumin ,3.3 g/dL
group compared with the SGA 5 A 1 s-albumin
$3.3 g/dL group (HR, 2.86; 95% CI, 1.66 to
4.94; P # .0001).
There was no statistical difference in mortality
risk among any combinations of s-albumin (, or
$3.3 g/dL) and BMI (, or $26 kg/m2) categories (P 5.53).
In summary, after adjusting for all variables,
including age, gender, dialysis modality, GFR level
at which dialysis started, s-albumin levels, BMI,
malnutrition score (SGA B and C), smoking,
and all co-morbidities, advanced age (.65 years;
P ,.0001), presence of PVD (P ,.0001), reduced
s-albumin levels (P 5.01), and malnutrition scored
as SGA B and C (P 5.02) independently predicted
mortality. Combined effects of SGA A with BMI
,26 kg/m2 or s-albumin $3.3 g/dL were associated with better survival.

Discussion
Our cohort represented a relatively homogenous group of ESKD patients who showed an
uneventful but gradual decline of renal function
with no history of AKI and RRT. We observed
a high prevalence (52.1%) of malnutrition (SGA
B and C) at the start of dialysis. Malnutrition, together with advanced age, reduced s-albumin
levels, and presence of PVD independently
predicted mortality during the 10-year study period. Gender, dialysis modalities, GFR level at
which dialysis was commenced, BMI, positive
smoking history, and comorbidities other than
PVD did not show any statistically signiﬁcant effect on mortality risk.
In search of the optimal timing for when dialysis
should start, the IDEAL trial37 compared the mortality between early- (10 to 14 mL/minutes/1.73 m2)
and late-start (5 to 7 mL/minutes/1.73 m2) groups.
The mean GFR of the early- and late-starting group
resulted at 12.0 mL/minutes/1.73 m2 and 9.8 mL/
minutes/1.73 m2, respectively, in the study because
of various clinical and social decisions. No statistical
difference in survival or clinical outcomes was
observed between the early- or late-starting groups.
Our cohort study, which included patients with
a wider range of clinical implications, also showed
no difference in mortality risk when the analyses
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were performed at the GFR cutoff of 7 mL/minutes/1.73 m2, as initially planned in the IDEAL trial,
or at the cutoff of 8, 9, and 10 mL/minutes/1.73 m2.
Our results supported the recommendations of the
IDEAL trial and other observational studies35,44
that with careful clinical management of ESKD,
including nutritional inputs, dialysis can be started
at lower levels of GFR (,7 mL/minutes/1.73
m2).34,45 In agreement with the literature, we
found no signiﬁcant difference in mortality risk between HD and PD.28,42 This suggests patients
should be able to start on either modalities based
on their clinical and psychosocial needs when the
time is right.
The effects of hypoalbuminemia on mortality
have been inconsistent in the literature46-48
because of reasons such as the presence of inﬂammation (duration and magnitude) and duration
and the severity of hypoalbuminemia. The present
study indicated that s-albumin levels were an
independent predicator of mortality. This result
was consistent with the ﬁndings of a number of
studies,23,47,49,50 but differed from others.28,48,51
In the latter studies, the predictive effect of
s-albumin was ameliorated after adjusting for
CRP, and this may be a limitation of our study
because CRP was not routinely measured.
Therefore, the independent predictive effect of
s-albumin as solely nutritional could not be concluded. However, we did consider for other study
variables, including the known associates of
inﬂammation such as history of AKI, surgery (PD
catheter insertion), obesity, and other comorbidities. Thus, it is reasonable to speculate the strong
role of poor nutrition or type I malnutrition caused
by a reduced protein and energy intake2 plays in the
predictive effect of s-albumin levels in our study,
similar to other reports in the literature.19,29
Similar to previous ﬁndings, the SGA rating of
malnutrition was found to be an independent predictor of mortality.28,49,52 A sustained reduction of
dietary intake is a major determinant of SGA rating, and as we considered sustained intakes of protein and energy of less than 80% of requirements as
inadequate, it was reasonable to deduce that the
predictive effect of low s-albumin levels constituted a signiﬁcant nutrition component. It is possible that both type I and type II malnutrition
coexist with nutritional and inﬂammatory factors
compounding the effects on each other, and their
signiﬁcance cannot be mutually exclusive. We did
not examine the effect of the individual compo-

nents of SGA on survival, but it is known that
these individual components reﬂect long-term
changes and are highly predictive of mortality
and morbidities, such as unintentional weight
loss,19,53 reduced dietary intake,50,54,55 poor appetite,26,56 and muscle wasting.57 Our study supports
the use of SGA score at the start of dialysis as a powerful independent predictor of survival, as previously reported by other researchers.28,49,52
In contrast to the literature,28,49,50 diabetes was
not observed to be associated with higher mortality risk in our study. This may be explained by
a higher proportion of our patients with diabetes
being well nourished, possibly counteracting the
effects of the uremic wasting on mortality over
time. Our results were similar to those of the
Dialysis Outcomes and Practice Patterns Study
(DOPPS)58 which reported diabetic patients
had signiﬁcantly lower odds of cachectic appearance than nondiabetic patients. Cardiovascular
disease was found to be an independent predictor
of mortality in several studies.28,49,59 We found
CAD to be signiﬁcant in the unadjusted analyses,
but the signiﬁcance disappeared in the adjusted
analyses (HR, 1.45; 95% CI, 0.94 to 2.19;
P 5 .10). This can possibly be explained by the
unknown duration and severity of cardiovascular
conditions in our cohort. Also, our patients
were much older (mean age, 65.3 6 13.6 years
compared with 50 to 56 years in these studies),
and the age factors may explain some of the variation in our ﬁndings. Other reasons could be the
varied observational periods or the heterogeneity
of uremia-related nutritional effects before starting dialysis in previous studies. Such reasons include unplanned initiation of dialysis because of
unforeseen events (e.g., AKI caused by infections
and surgical complications), duration of malnutrition, and previous transplantation. It is not clear
whether dialysis was initiated for the same reasons
in all patients in reported studies.
The obesity paradox32,33,60,61 has created much
debate in the renal community regarding the protective effect of obesity in ESKD patients. A recent
systematic review62 of the relationship between
BMI and mortality supported the inverse association between BMI and all-cause mortality in adult
(HD) patients, especially in elderly patients. In
other studies,50,63,64 it has been argued that
when body composition was also considered, the
possible protective effect of high BMI is limited
to subjects with normal and high muscle mass
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only. Similarly to previous ﬁndings,31,65 our study
revealed being overweight or obese was not
found to have any protective effects, and when
combining with malnutrition scores, it was associated with the worst outcome. Our ﬁndings echoed
the high mortality risk found in those with obese
sarcopenia.66 In addition, the combined effects
SGA A and BMI ,26 kg/m2 were found to
have the best survival advantage. Again, higher
BMI did not show protective effects with either
low or normal levels of s-albumin. Most importantly, being well nourished (SGA A) was found
to be associated with lower mortality risk irrespective of the levels of s-albumin and BMI. Our study
highlighted the usefulness of the combined effects
of nutritional parameters in predicting outcomes.
There are limitations to our study. The main
ones are the lack of measurement of inﬂammatory
biomarkers (CRP), small sample size, and unknown duration and severity of lifestyle factors
such as smoking history and comorbidities (e.g.,
CAD). We also did not measure the effect of
nutrition interventions before and after dialysis
initiation. Patients may respond to nutritional
management differently depending on the type,
severity, and duration of their nutritional issues,
and the degree of exposure to intervention. Our
study points to the need for timely access to structured nutritional care to prevent and manage
nutritional abnormalities well before dialysis is required, and if it is required, to help maintain nutrition status on the conservative management
pathway.
The strength of this study is the long follow-up
time in a well-deﬁned cohort of patients experiencing relatively homogeneous nutritional effects
before dialysis started. It is a good example of
how informative research can be conducted
within the practice of renal care.

Conclusions
In the study reported here, a high prevalence of
malnutrition among patients with ESKD at the
initiation of dialysis was observed. During
a 10-year period, advanced age (.65 years),
reduced s-albumin levels, presence of PVD, and
malnutrition scores were found to independently
predict mortality. Other studied factors, such as
gender, dialysis modality, GFR level at which dialysis was initiated, BMI, positive smoking history,
and presence of all other comorbidities, were not
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found to be associated with higher mortality
risk. A high BMI was not associated with any survival advantage, and when combined with the
presence of malnutrition, it was associated with
the highest mortality risk. The combined effects
of these simple readily available nutritional parameters were effective in predicting mortality independently and are highly informative for practice
management and evaluation.

Practical Application
Malnutrition scored by SGA (B and C) at the
start of dialysis was associated with high mortality
risk irrespective of the BMI and s-albumin levels.
Being overweight or obese did not show any protective effect and was associated with the worst
outcome with the presence of malnutrition. These
ﬁndings suggest nutrition intervention to optimize nutritional status should be considered in patients with ESKD well before dialysis is required.
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